S. Lim

Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic Transport

C. Porter, N. Trevaskis, T. Quach, 2022, Frontiers in Pharmacology.

Targeted delivery of mycophenolic acid to the mesenteric lymph node using a triglyceride mimetic prodrug approach enhances gut-specific immunomodulation in mice.

U. V. von Andrian, J. Mintern, C. Nowell, 2021, Journal of controlled release : official journal of the Controlled Release Society.

Glyceride-Mimetic Prodrugs Incorporating Self-Immolative Spacers Promote Lymphatic Transport, Avoid First-Pass Metabolism, and Enhance Oral Bioavailability.

C. Porter, N. Trevaskis, T. Quach, 2016, Angewandte Chemie.

Reactions of Thiiranium and Sulphonium ions with Alkenes in the Gas-phase.

J. White, P. Maître, R. O'hair, 2019, The Journal of organic chemistry.

Transformation of Biopharmaceutical Classification System Class I and III Drugs Into Ionic Liquids and Lipophilic Salts for Enhanced Developability Using Lipid Formulations.

C. Pouton, C. Porter, H. Williams, 2018, Journal of Pharmacy and Science.

Enhancing the Oral Absorption of Kinase Inhibitors Using Lipophilic Salts and Lipid-Based Formulations.

David M. Shackleford, C. Pouton, C. Porter, 2018, Molecular pharmaceutics.

The impact of conjugation position and linker chemistry on the lymphatic transport of a series of glyceride and phospholipid mimetic prodrugs.

C. Porter, N. Trevaskis, T. Quach, 2020, Journal of pharmaceutical sciences.

Increasing Linker Chain Length and Intestinal Stability Enhances Lymphatic Transport and Lymph Node Exposure of Triglyceride Mimetic Prodrugs of a Model Immunomodulator Mycophenolic Acid.

Garima Sharma, C. Porter, N. Trevaskis, 2023, Molecular pharmaceutics.